A potential vaccine for coronavirus disease 2019 (Covid-19) developed by a Chinese pharmaceutical had been cleared for clinical trials in the country, an official of the Food and Drug Administration (FDA) said on Thursday.
Health Undersecretary Eric Domingo, FDA officer in charge, confirmed that the vaccine expert panel (VEP) from the Department of Science and Technology (DoST) approved the Sinovac drug for Phase 3 trials.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.